N4 Pharma is a biotech company developing Nuvec^®, its proprietary gene delivery system, to enable advanced therapies for cancer and other diseases.

Our lead programme, N4 101, is a dual-targeting, orally delivered RNA theraputic designed to improve the lives of patients with inflammatory bowel disease.